Institutional members access full text with Ovid®

Share this article on:

Understanding and Treating Comorbid Anxiety Disorders in Substance Users: Review and Future Directions

Wolitzky-Taylor, Kate PhD; Operskalski, Joachim T. BA; Ries, Richard MD; Craske, Michelle G. PhD; Roy-Byrne, Peter MD

doi: 10.1097/ADM.0b013e31823276d7
Review

Anxiety disorders commonly occur among those with substance use disorders. This article reviews the literature describing the prevalence and patterns of this comorbidity in epidemiological and clinical samples and theoretical models explaining this comorbidity, and reviews the effects of anxiety disorders on substance use outcomes and data from clinical trials that target comorbid anxiety disorders to examine the effects of treating anxiety disorders on substance use outcomes. Next, this review outlines evidence-based pharmacological and psychological treatments for anxiety disorders and provides treatment recommendations for those treating this comorbid population. Finally, a discussion of treatment-delivery issues is presented to address the important issues that arise when treating anxiety disorders in typical addictions-treatment settings.

From the University of California (KW-T, MGC), Los Angeles, CA; and University of Washington (JTO, RR, PR-B), Seattle, WA.

Send correspondence and reprint requests to Kate Wolitzky-Taylor, PhD, UCLA Department of Psychology, 405 Hilgard Ave, Los Angeles, CA 90024. E-mail: ktaylor@psych.ucla.edu.

Received April 11, 2011

Accepted August 10, 2011

© 2011 American Society of Addiction Medicine